Skip to content
Resources > Reports

Navigating Biopharma Policy: 2025 Changes and a Look Ahead

By Sara Mallatt, Director of Healthcare Research and Sean Carmichael
IndustryLife Sciences & Healthcare

Biopharma firms are grappling with a turbulent and complex policy landscape. The threat of 100% tariffs on imported branded drugs have fundamentally altered business strategy for firms, spurring dealmaking with the federal government in exchange for tariff relief. Heightened policy uncertainty is forcing manufacturers to reevaluate pricing and go-to-market strategies, with a severe expected revenue impact.

AlphaSense recently hosted a webinar with Dr. Robert Popovian, Chief Science Policy Officer at the Global Health Living Foundation to discuss these issues and more. This report leverages key insights from Dr. Popovian and those available in AlphaSense to explore the key policy shifts shaping the biopharma ecosystem.

About the Authors

  • Sara Mallatt, Director of Healthcare Research

    Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.

  • Sean Carmichael

    Sean is a Business & Finance Editor at AlphaSense, specializing in sector-specific content production. Previously, he spent nearly a decade in various roles across financial services, where he was responsible for equity research and content generation geared toward institutional investors.

Explore more

All articles

The VC Playbook: How to Spot a Purple Cow in Crowded Pastures

In this playbook, we leverage insights from Harry Stebbings of 20VC to answer this question among others, including: What are the characteristics of successful early stage companies? Which unconventional criteria play an important role in securing deals?
ReportFinancial Services
Title slide for 'The Venture Capital Playbook: How to Spot a Purple Cow in Crowded Pastures,' featuring outlined illustrations of a purple cow and a white bull.

Execution in Focus: Tracking Key Healthcare and Biopharma Trends in 2026

This report tackles these issues and other key trends shaping the healthcare landscape in early 2026.
ReportLife Sciences & HealthcareFinancial Services
Title slide: Tracking Key Healthcare and Biopharma Trends in 2026 by Sara Mallatt and Sean Carmichael, featuring data graphs and medical icons.

Top AI Use Cases for Investment Banking

In this report, we explore how AI is transforming IB workflows by streamlining and accelerating intelligence and insights at scale.
ReportFinancial Services
Blue graphic for an article titled 'Top AI Use Cases For Investment Banking,' featuring white blueprint-style outlines of a skyscraper, dollar sign, and euro symbol on a grid.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.